Eilon Krashin

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Translational Hemato-Oncology Laboratory, Meir Medical Center, Kfar-Saba, Israel

Posts

Managing antiplatelet therapy in thrombocytopenic patients with hematological malignancy
Anticoagulation Drugs

Managing antiplatelet therapy in thrombocytopenic patients with hematological malignancy

The use of antiplatelet therapy, prescribed for acute and chronic ischemic arterial disease, is frequently encountered in cancer patients. A clinical vignette-based experiment was designed to mimic the clinical scenarios in which decision-making occurs.

Read More